Canada Life’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,493
Closed -$6.5M 2408
2022
Q3
$6.5M Buy
26,493
+1,820
+7% +$491K 0.02% 609
2022
Q2
$6.11M Sell
24,673
-6,583
-21% -$1.78M 0.02% 639
2022
Q1
$10.9M Sell
31,256
-657
-2% -$202K 0.02% 555
2021
Q4
$11.4M Buy
31,913
+655
+2% +$221K 0.02% 556
2021
Q3
$10.2M Buy
31,258
+1,160
+4% +$393K 0.02% 574
2021
Q2
$9.39M Buy
30,098
+7,080
+31% +$2.17M 0.02% 619
2021
Q1
$7.3M Buy
23,018
+969
+4% +$310K 0.02% 658
2020
Q4
$7.13M Buy
22,049
+163
+0.7% +$45.1K 0.01% 700
2020
Q3
$6.06M Sell
21,886
-7,030
-24% -$2.03M 0.01% 659
2020
Q2
$6.96M Buy
28,916
+37
+0.1% +$7.43K 0.02% 618
2020
Q1
$4.21M Sell
28,879
-5,812
-17% -$965K 0.01% 680
2019
Q4
$5.88M Sell
34,691
-3,037
-8% -$563K 0.01% 683
2019
Q3
$6.71M Buy
37,728
+2,701
+8% +$584K 0.02% 612
2019
Q2
$9.12M Buy
+35,027
New +$9.29M 0.02% 577
2019
Q1
Sell
-28,583
Closed -$8.85M 2714
2018
Q4
$8.85M Buy
28,583
+749
+3% +$260K 0.03% 497
2018
Q3
$12.5M Buy
27,834
+6,477
+30% +$2.55M 0.03% 450
2018
Q2
$8.74M Sell
21,357
-5,769
-21% -$2.09M 0.02% 569
2018
Q1
$7.9M Sell
27,126
-2,850
-10% -$722K 0.02% 594
2017
Q4
$5.62M Sell
29,976
-860
-3% -$161K 0.01% 681
2017
Q3
$5.16M Buy
30,836
+5,822
+23% +$880K 0.01% 687
2017
Q2
$3.58M Buy
25,014
+1,063
+4% +$143K 0.01% 811
2017
Q1
$3M Buy
23,951
+1,126
+5% +$131K 0.01% 894
2016
Q4
$2.57M Sell
22,825
-1,143
-5% -$132K 0.01% 945
2016
Q3
$3.08M Buy
23,968
+587
+3% +$70.3K 0.01% 829
2016
Q2
$2.55M Buy
23,381
+18,473
+376% +$1.84M 0.01% 891
2016
Q1
$465K Hold
4,908
﹤0.01% 927
2015
Q4
$443K Buy
4,908
+1,347
+38% +$114K ﹤0.01% 938
2015
Q3
$331K Sell
3,561
-35
-1% -$3.08K ﹤0.01% 1002
2015
Q2
$236K Buy
3,596
+35
+1% +$2.33K ﹤0.01% 1289
2015
Q1
$254K Buy
3,561
+1,400
+65% +$76K ﹤0.01% 1231
2014
Q4
$82K Hold
2,161
﹤0.01% 1874
2014
Q3
$54K Hold
2,161
﹤0.01% 2011
2014
Q2
$54K Hold
2,161
﹤0.01% 1915
2014
Q1
$56K Hold
2,161
﹤0.01% 1727
2013
Q4
$58K Sell
2,161
-4,400
-67% -$109K ﹤0.01% 1699
2013
Q3
$125K Buy
+6,561
New +$150K ﹤0.01% 961

Other funds holding ABMD